Riktkurs.nu
EN | SV
There is a problem with the stock price data. Our supplier is working to solve the issue.
SkistarMid CapSynsam
Stockholm Stock Exchange | Mid Cap
Synact Pharma
-12.38%
Latest
-
3 months
DNB MarketsDNBABG Sundal CollierKempen

Price Targets For Synact Pharma

AnalystPrice TargetDateUpside
DNB Markets15 SEKSep 5
-12.38%
DNB170 SEKAug 31
ABG Sundal Collier170 SEKDec -21
Kempen125 SEKJun -21

About The Company

SynAct Pharma is a clinical stage biotechnology company focused on resolving inflammation with melanocortin biology. Selective activation of the melanocortin system can help the immune system resolve excessive or chronic inflammation.
Synact Pharma

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2023